BRD4-IN-7, with the CAS number 1446232-98-9, is a small molecule inhibitor specifically targeting the bromodomain and extraterminal (BET) family of proteins, particularly BRD4. This compound is characterized by its ability to disrupt the interaction between BRD4 and acetylated lysines on histones, thereby influencing gene expression and cellular processes. It is often studied in the context of cancer research, as BRD4 plays a significant role in the regulation of oncogenes and is implicated in various malignancies. The compound typically exhibits a moderate to high affinity for its target, making it a valuable tool in both basic research and potential therapeutic applications. Additionally, BRD4-IN-7 is usually evaluated for its pharmacokinetic properties, including solubility, stability, and bioavailability, which are crucial for its effectiveness in vivo. As with many small molecule inhibitors, its specificity and potential off-target effects are also important considerations in its development and application in therapeutic settings.

BRD4-IN-7

1446232-98-9: BRD4-IN-7, with the CAS number 1446232-98-9, is a small molecule inhibitor specifically targeting the bromodomain and extraterminal (BET) family of proteins, particularly BRD4. This compound is characterized by its ability to disrupt the interaction between BRD4 and acetylated lysines on histones, thereby influencing gene expression and cellular processes. It is often studied in the context of cancer research, as BRD4 plays a significant role in the regulation of oncogenes and is implicated in various malignancies. The compound typically exhibits a moderate to high affinity for its target, making it a valuable tool in both basic research and potential therapeutic applications. Additionally, BRD4-IN-7 is usually evaluated for its pharmacokinetic properties, including solubility, stability, and bioavailability, which are crucial for its effectiveness in vivo. As with many small molecule inhibitors, its specificity and potential off-target effects are also important considerations in its development and application in therapeutic settings.

<p>BRD4-IN-7, also known as compound 120, acts as a BRD4 inhibitor.</p>

CAS 1446232-98-9

BRD4-IN-7

BRD4-IN-7

Ref: TM-T85914